Poly dispersed acid-functionalized single walled carbon nanotubes target activated T and B cells to suppress GVHD in mouse model
Abstract
Graft versus host disease (GVHD) results from hyper-activation of transplanted lymphocytes against the host antigens. Bone marrow transplantation in humans as well as some cases of blood transfusion and organ transplantation are associated with a strong GVH reaction resulting in GVHD that in many cases may be fatal. We had previously shown that poly-dispersed acid-functionalized single-walled carbon nanotubes (AF-SWCNTs) specifically target activated T and B lymphocytes and kill them. In the present study, efficacy of AF-SWCNTs to suppress the GVH reaction was tested in the mouse model. Acute GVHD was induced in mice by administering intravenously 30 or 60 million spleen cells from a parental strain (C57bl/6 mouse, MHC haplotype H-2b) to host (C57bl/6 x Balb/c) F1 mice (MHC haplotype H-2b/d) and waiting for 8-10 days. Chronic GVHD was similarly induced by administration of 30 million parent spleen cells to F1 mice and waiting for a period of 60 days. Our results demonstrate a marked decline in splenomegaly and recovery of spleen T (both CD4 and CD8) and B cells in GVHD mice treated with AF-SWCNTs. AF-SWCNTs treatment also limited T and B cell proliferation by restricting S-phage of cell cycle. Generation of anti-host cytotoxic T cells (CTLs) was also markedly suppressed by AF-SWCNT treatment of acute GVHD mice, and a significant reduction in the generation of anti-host antibodies could also be demonstrated. Taken together, our results suggest that the AF-SWCNTs can be considered as a potential therapeutic agent for treating GVHD.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Role of N-acetylcysteine Amide in Acute Graft-versus-host Disease Mouse Model
Rui He, Wenyi Zheng, … Moustapha Hassan·bioRxiv·Apr 7, 2025
- Donor-Targeted Anti-HLA-A2 Antibody Shows Nanogram-Level Efficacy in a Novel GVHD Mouse Model
Kouta Niizuma, Alyssa H Chang, … Yusuke Nakauchi·Blood AdvancesPeer-reviewed·Jul 21, 2026
- Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues ameliorating GVHD post-HSCT
Duneia McManus, Sabrina N. Copsel, … Robert B. Levy·BloodPeer-reviewed·Aug 1, 2025
- TCF-1 in CD4 T cells regulates GVHD severity and persistence
R. Harris, M. Mammadli, … M. Karimi·bioRxiv·Mar 22, 2021
- Wnt/β-catenin regulates alloreactive T cells for the treatment of hematological malignancies
M. Mammadli, R. Harris, … M. Karimi·bioRxiv·Apr 12, 2021
- Donor monocyte-derived macrophages promote human acute graft versus host disease
L. Jardine, U. Cytlak, … M. Collin·bioRxiv·Sep 30, 2019